On Tuesday 11 July 2017 Canada committed to spend up to $241.5 million to support projects that will provide “critical sexual and reproductive health services,” filling some of the void left behind by the Trump administration. International Development Minister Marie-Claude … Continued
In 2015, Abortion Access Now PEI legally challenged the restrictive abortion policy of Prince Edward Island. This article studies their challenge as a unique case in the building of a constitutional future for abortion rights in Canada. The article tracks how AAN PEI drew on classic rule of law arguments of transparency, accountability, and constitutional justice to shape and claim abortion rights as democratic rights, an entitlement to fully and equally participate in and benefit from the health care system as a fundamental social institution of the state.
This decision from Rachel Notley’s New Democratic Party government makes Alberta the second province in Canada to say that it will offer universal access to Mifegymiso, the combined medical abortion kit that received an important endorsement from an expert committee … Continued
The New Brunswick Health Minister Victor Boudreau said he wanted to reduce financial barriers to a woman’s right to choose. Any woman with a valid Medicare card would be able to get Mifegymiso (combi=pack of mifepristone + misoprostol) free. The … Continued
Mifegymiso, the medical abortion pill packet, has been available in Canada since late January 2017. However, three months after the pills became available, only five provinces and one territory have requested it, according to its manufacturer: Ontario, Manitoba, Saskatchewan, Alberta, … Continued
Shipments of the combination pack of the two pills, mifepristone and misoprostol, used for medical abortion finally began arriving in Canada at two clinics in Vancouver and Calgary during the week of 16 January 2017. Misoprostol has long been available … Continued
City officials in Grande Prairie, in northwest Alberta province, rejected a confrontational advertisement for the side of the city’s municipal buses, which led to a two-year court battle between the anti-abortion group claiming the right to freedom of expression against the city’s authority to decide what is appropriate and what is not appropriate for putting on the side of their municipal buses.
According to Dr Wendy Thomas, a family doctor, and Prof Judith A Soon, Faculty of Pharmaceutical Sciences, University of British Colombia, the federal government must allow pharmacists to prescribe the abortion pill to ensure safe and equitable access for women across Canada.
Assessing abortion coverage in nurse practitioner programs in Canada, abortion training in Canadian obstetrics and gynecology residency programs and “They made me go through like weeks of appointments and everything”: Documenting women’s experiences seeking abortion care in Yukon territory, Canada.
Celopharma Inc, the company that is bringing the combined abortion pill package of mifepristone+misoprostol to Canada is going ahead with a crucial cost-effectiveness review by the Common Drug Review (CDR) that could clear the way for provincial drug plans to cover the CAN $300 cost of the medication, according to Health Canada.